PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 4, 2026Translational Oncology0 citationsOpen Access

Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer: a spatial perspective

View Full Paper
KZKe ZhaoQYQiting YangYYYuhan Yan

Key Points

  • This review aims to explore the spatially heterogeneous distribution of tumor-infiltrating lymphocytes in pancreatic cancer and how it contributes to disease progression and treatment resistance.
  • Synthesis of recent research findings on lymphocyte distribution in pancreatic ductal adenocarcinoma (PDAC).
  • Examination of the functional states and ontogeny of region-specific tumor-infiltrating lymphocyte subsets.
  • Discussion of technical challenges and emerging technologies in PDAC immuno-oncology.
  • Identified distinct distribution patterns of TILs between intratumoral and peritumoral regions.
  • Highlighted how spatial heterogeneity impacts disease progression and reduces the effectiveness of immunotherapy.
  • Outlined reciprocal interactions between immunosuppressive stroma and lymphocyte heterogeneity.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by a profoundly immunosuppressive and spatially heterogeneous tumor microenvironment. Recent research has focused on the distinct topographic distribution of tumor-infiltrating lymphocytes (TILs) across intratumoral and peritumoral compartments. This review synthesizes the latest advances, delineating the distribution, functional states, and ontogeny of region-specific TIL subsets, and dissects how spatial heterogeneity fuels disease progression and resistance to immunotherapy. We further explore the reciprocal crosstalk between immunosuppressive stroma and lymphocyte heterogeneity, highlight prevailing technical and conceptual challenges, and outline emerging technologies poised to shape the next phase of discovery. This work provides a comprehensive roadmap to accelerate translation in PDAC immuno-oncology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhao et al. (2026) studied this question.

synapsesocial.com/papers/6a211591d499ed480b16e9aehttps://doi.org/10.1016/j.tranon.2026.102823
Ask AI
Helpful
Bookmark
Share
View Full Paper